Form4insider filings, from the source

SEC Form 4 · accession 0001232524-16-000325

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 11, 2016
Accepted (ET)
Aug 15, 2016 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Aug 11, 2016A1,365$0.00A2,675D
Ordinary SharesF2holding———4,323IBy Longitude Capital
Ordinary SharesF2holding———215,677IBy Longitude Venture

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F3$138.08Aug 11, 2016A3,415A—Aug 10, 2026Ordinary Shares3,4153,415D

Explanation of responses